• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物偶联:靶向药物输送的新平台。

Bioconjugation of polymers: a novel platform for targeted drug delivery.

机构信息

Department of Pharmaceutical Sciences Dr. Hari Singh Gour Vishwavidyalaya, Sagar, India.

出版信息

Curr Pharm Des. 2011;17(11):1108-25. doi: 10.2174/138161211795656873.

DOI:10.2174/138161211795656873
PMID:21434852
Abstract

Bioconjugation, a novel technique is usually exploited to improve the biopharmaceutical aspects of a bioactive as well as afford its spatial and temporal distribution. The strategy enlightens newer vistas for delivery of drugs, peptides, enzymes, and oligonucleotides. Site specific delivery may be obtained by tailoring the conjugates as an inactive prodrug and designing polymer drug linkages susceptible to cleavage by specific enzymes or pH. These prodrugs substantially change the mechanisms of cellular entry, pharmacokinetic disposition and ultimately target the drug. The conjugate vehicles are being exploited for targeting pharmacological agents to visceral tissues viz brain, colon etc. These biomaterials are bringing into play, novel drug delivery systems for selectively and specifically ferrying drugs to the desired organ. Noteworthy contributions reported with bioconjugated nanoparticles for biosensing and bioimaging incorporate cell staining, DNA detection, separation and recombination relevance in DNA protection. Only recently, these tailor-made polymers have also gained impetuous for enzyme therapy, gene therapy, insulin therapy, cancer therapy and management of AIDS with the interception of minimal side effects. The present review exhaustively provides an insight to the polymer bioconjugates and their implications for targeted delivery. The article also discusses the therapeutic aspects of these conjugates and that these may serve as fascinating tools for drug delivery.

摘要

生物共轭物是一种新型技术,通常用于改善生物活性物质的生物制药方面,并提供其空间和时间分布。该策略为药物、肽、酶和寡核苷酸的传递提供了新的视角。通过将缀合物设计为无活性前药,并设计对特定酶或 pH 敏感的聚合物药物键,可以实现靶向递药。这些前药会显著改变细胞进入、药代动力学分布的机制,并最终靶向药物。缀合物载体正被用于将药理学制剂靶向内脏组织,如脑、结肠等。这些生物材料正在为选择性和特异性地将药物递送到所需器官发挥作用,新型药物传递系统。值得注意的是,生物共轭纳米粒子在生物传感和生物成像方面的报告包括细胞染色、DNA 检测、分离和重组在 DNA 保护中的相关性。直到最近,这些定制聚合物也因酶治疗、基因治疗、胰岛素治疗、癌症治疗和艾滋病管理而获得了动力,同时可以拦截最小的副作用。本综述全面介绍了聚合物生物共轭物及其在靶向递药中的应用。文章还讨论了这些缀合物的治疗方面,它们可以作为药物传递的迷人工具。

相似文献

1
Bioconjugation of polymers: a novel platform for targeted drug delivery.聚合物偶联:靶向药物输送的新平台。
Curr Pharm Des. 2011;17(11):1108-25. doi: 10.2174/138161211795656873.
2
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
3
Designing polymer conjugates as lysosomotropic nanomedicines.设计聚合物缀合物作为溶酶体亲和性纳米药物。
Biochem Soc Trans. 2007 Feb;35(Pt 1):56-60. doi: 10.1042/BST0350056.
4
Bioconjugates: harnessing potential for effective therapeutics.生物偶联物:挖掘有效治疗方法的潜力。
Crit Rev Ther Drug Carrier Syst. 2009;26(2):119-55. doi: 10.1615/critrevtherdrugcarriersyst.v26.i2.10.
5
Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery.适体介导的聚合物载体用于增强细胞靶向药物递送。
Curr Drug Targets. 2018 Feb 8;19(3):248-258. doi: 10.2174/1389450117666160617120926.
6
Polymer-drug conjugates: present state of play and future perspectives.聚合物-药物偶联物:现状与未来展望
Drug Discov Today. 2013 Dec;18(23-24):1316-22. doi: 10.1016/j.drudis.2013.09.007. Epub 2013 Sep 17.
7
Role of polymer-drug conjugates in organ-specific delivery systems.聚合物-药物偶联物在器官特异性递送系统中的作用。
J Drug Target. 2015 Jun;23(5):387-416. doi: 10.3109/1061186X.2015.1016436. Epub 2015 Feb 27.
8
pH-responsive polymer-drug conjugates: Design and progress.pH 响应型聚合物-药物偶联物:设计与进展。
J Control Release. 2016 Jan 28;222:116-29. doi: 10.1016/j.jconrel.2015.12.024. Epub 2015 Dec 17.
9
Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.抗CD20单克隆抗体靶向与非靶向星形聚合物前药缀合物的抗淋巴瘤疗效比较
Molecules. 2015 Nov 4;20(11):19849-64. doi: 10.3390/molecules201119664.
10
Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.聚合物纳米粒子与肽、糖和小分子的肿瘤靶向结合用于抗癌药物。
Curr Pharm Des. 2017;23(35):5349-5357. doi: 10.2174/1381612823666170608081735.

引用本文的文献

1
Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy.聚合物-药物偶联物:革新用于诊断和治疗的纳米诊疗剂
Discov Oncol. 2024 Nov 11;15(1):641. doi: 10.1007/s12672-024-01509-9.
2
An Overview of Nanotechnologies for Drug Delivery to the Brain.用于脑部药物递送的纳米技术概述。
Pharmaceutics. 2022 Jan 19;14(2):224. doi: 10.3390/pharmaceutics14020224.
3
Optically Active Nanomaterials for Bioimaging and Targeted Therapy.用于生物成像和靶向治疗的光学活性纳米材料。
Front Bioeng Biotechnol. 2019 Nov 15;7:320. doi: 10.3389/fbioe.2019.00320. eCollection 2019.
4
CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.用于乳腺癌靶向雷帕霉素化疗的CD44靶向聚合物纳米载体
Nanomedicine. 2014 Aug;10(6):1221-30. doi: 10.1016/j.nano.2014.02.015. Epub 2014 Mar 15.
5
Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.基于结构的 G 蛋白偶联腺苷和 P2Y 受体配体方法,从小分子到纳米缀合物。
J Med Chem. 2013 May 23;56(10):3749-67. doi: 10.1021/jm400422s. Epub 2013 May 9.
6
Challenges in design and characterization of ligand-targeted drug delivery systems.配体靶向药物传递系统的设计和表征面临的挑战。
J Control Release. 2012 Dec 10;164(2):125-37. doi: 10.1016/j.jconrel.2012.05.052. Epub 2012 Jun 15.